|
1
|
Davies PF, Manduchi E, Jimenez JM and
Jiang YZ: Biofluids, cell mechanics and epigenetics: Flow-induced
epigenetic mechanisms of endothelial gene expression. J Biomech.
50:3–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takeshima H, Wakabayashi M, Hattori N,
Yamashita S and Ushijima T: Identification of coexistence of DNA
methylation and H3K27me3 specifically in cancer cells as a
promising target for epigenetic therapy. Carcinogenesis.
36:192–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Agostini M, Enzo MV, Bedin C, Belardinelli
V, Goldin E, Del Bianco P, Maschietto E, D'Angelo E, Izzi L,
Saccani A, et al: Circulating cell-free DNA: A promising marker of
regional lymphonode metastasis in breast cancer patients. Cancer
Biomark. 11:89–98. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qi J, Zhu YQ, Luo J and Tao WH:
Hypermethylation and expression regulation of secreted
frizzled-related protein genes in colorectal tumor. World J
Gastroenterol. 12:7113–7117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagasaka T, Tanaka N, Cullings HM, Sun DS,
Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, et
al: Analysis of fecal DNA methylation to detect gastrointestinal
neoplasia. J Natl Cancer Inst. 101:1244–1258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li VS, Ng SS, Boersema PJ, Low TY,
Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi
T and Clevers H: Wnt signaling through inhibition of β-catenin
degradation in an intact Axin1 complex. Cell. 149:1245–1256. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Surana R, Sikka S, Cai W, Shin EM, Warrier
SR, Tan HJ, Arfuso F and Fox SA: Secreted frizzled related
proteins: Implications in cancers. Biochim Biophys Acta 1845.
53–65. 2014.
|
|
8
|
Takagi H, Sasaki S, Suzuki H, Toyota M,
Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K and
Shinomura Y: Frequent epigenetic inactivation of SFRP genes in
hepatocellular carcinoma. J Gastroenterol. 43:378–389. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Zhu YQ, Wu YQ, Zhang P and Qi J:
Detection of promoter hypermethylation of Wnt antagonist genes in
fecal samples for diagnosis of early colorectal cancer. World J
Gastroenterol. 20:6329–6335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chung MT, Sytwu HK, Yan MD, Shih YL, Chang
CC, Yu MH, Chu TY, Lai HC and Lin YW: Promoter methylation of SFRPs
gene family in cervical cancer. Gynecol Oncol. 112:301–306. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uhm KO, Lee ES, Lee YM, Kim HS, Park YN
and Park SH: Aberrant promoter CpG islands methylation of tumor
suppressor genes in cholangiocarcinoma. Oncol Res. 17:151–157.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin YW, Chung MT, Lai HC, De Yan M, Shih
YL, Chang CC and Yu MH: Methylation analysis of SFRP genes family
in cervical adenocarcinoma. J Cancer Res Clin Oncol. 135:1665–1674.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghasemi A, Rostami S, Chahardouli B,
Alizad Ghandforosh N, Ghotaslou A and Nadali F: Study of SFRP1 and
SFRP2 methylation status in patients with de novo acute
myeloblastic leukemia. Int J Hematol Oncol Stem Cell Res. 9:15–21.
2015.PubMed/NCBI
|
|
14
|
Taguchi YH, Iwadate M and Umeyama H: SFRP1
is a possible candidate for epigenetic therapy in non-small cell
lung cancer. BMC Med Genomics. 9 (Suppl 1):S282016. View Article : Google Scholar
|
|
15
|
Sui C, Ma J, Chen Q and Yang Y: The
variation trends of SFRP2 methylation of tissue, feces, and blood
detection in colorectal cancer development. Eur J Cancer Prev.
25:288–298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Q, Huang T, Ye G, Wang B and Zhang X:
Methylation of SFRP2 gene as a promising noninvasive biomarker
using feces in colorectal cancer diagnosis: A systematic
meta-analysis. Sci Rep. 6:333392016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YZ, Liu D, Zhao YX, Wang HT, Gao Y
and Chen Y: Aberrant promoter methylation of the SFRP1 gene may
contribute to colorectal carcinogenesis: A meta-analysis. Tumour
Biol. 35:9201–9210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kloten V, Becker B, Winner K, Schrauder
MG, Fasching PA, Anzeneder T, Veeck J, Hartmann A, Knüchel R and
Dahl E: Promoter hypermethylation of the tumor-suppressor genes
ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast
cancer screening. Breast Cancer Res. 15:R42013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suzuki H, Toyota M, Carraway H, Gabrielson
E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T,
et al: Frequent epigenetic inactivation of Wnt antagonist genes in
breast cancer. Br J Cancer. 98:1147–1156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol.
62:1006–1012. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zintzaras E and Ioannidis JP: HEGESMA:
Genome search meta-analysis and heterogeneity testing.
Bioinformatics. 21:3672–3673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brinkhuizen T, van den Hurk K,
Winnepenninckx VJ, de Hoon JP, van Marion AM, Veeck J, van Engeland
M and van Steensel MA: Epigenetic changes in basal cell carcinoma
affect SHH and WNT signaling components. PLoS One. 7:e517102012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stoehr R, Wissmann C, Suzuki H, Knuechel
R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, et
al: Deletions of chromosome 8p and loss of sFRP1 expression are
progression markers of papillary bladder cancer. Lab Invest.
84:465–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun J, Chen Z, Zhu T, Yu J, Ma K, Zhang H,
He Y, Luo X and Zhu J: Hypermethylated SFRP1, but none of other
nine genes ‘informative’ for western countries, is valuable for
bladder cancer detection in Mainland China. J Cancer Res Clin
Oncol. 135:1717–1727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Wang H, Bu R, Fei X, Zhao C and
Song Y: Methylation and aberrant expression of the Wnt antagonist
secreted Frizzled-related protein 1 in bladder cancer. Oncol Lett.
4:334–338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Veeck J, Niederacher D, An H, Klopocki E,
Wiesmann F, Betz B, Galm O, Camara O, Dürst M, Kristiansen G, et
al: Aberrant methylation of the Wnt antagonist SFRP1 in breast
cancer is associated with unfavourable prognosis. Oncogene.
25:3479–3488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Yang B, Du Z, Gao YT, Wang YJ,
Jing X and Bai T: Identification and validation of specific
methylation profile in bile for differential diagnosis of malignant
biliary stricture. Clin Biochem. 43:1340–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Caldwell GM, Jones C, Gensberg K, Jan S,
Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM and Morton DG:
The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res.
64:883–888. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dhir M, Montgomery EA, Glöckner SC,
Schuebel KE, Hooker CM, Herman JG, Baylin SB, Gearhart SL and Ahuja
N: Epigenetic regulation of WNT signaling pathway genes in
inflammatory bowel disease (IBD) associated neoplasia. J
Gastrointest Surg. 12:1745–1753. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patai ÁV, Valcz G, Hollósi P, Kalmár A,
Péterfia B, Patai Á, Wichmann B, Spisák S, Barták BK, Leiszter K,
et al: Comprehensive DNA methylation analysis reveals a common
ten-gene methylation signature in colorectal adenomas and
carcinomas. PLoS One. 10:e01338362015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Salehi R, Mohammadi M, Emami MH and Salehi
AR: Methylation pattern of SFRP1 promoter in stool sample is a
potential marker for early detection of colorectal cancer. Adv
Biomed Res. 1:872012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Bauer M, Croner RS, Pelz JO,
Lodygin D, Hermeking H, Stürzl M, Hohenberger W and Matzel KE: DNA
stool test for colorectal cancer: Hypermethylation of the secreted
frizzled- related protein-1 gene. Dis Colon Rectum. 50:1618–1627.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rawson JB, Manno M, Mrkonjic M, Daftary D,
Dicks E, Buchanan DD, Younghusband HB, Parfrey PS, Young JP,
Pollett A, et al: Promoter methylation of Wnt antagonists DKK1 and
SFRP1 is associated with opposing tumor subtypes in two large
populations of colorectal cancer patients. Carcinogenesis.
32:741–747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Domenico M, Santoro A, Ricciardi C,
Iaccarino M, Iaccarino S, Freda M, Feola A, Sanguedolce F, Losito
S, Pasquali D, et al: Epigenetic fingerprint in endometrial
carcinogenesis: The hypothesis of a uterine field cancerization.
Cancer Biol Ther. 12:447–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clement G, Braunschweig R, Pasquier N,
Bosman FT and Benhattar J: Alterations of the Wnt signaling pathway
during the neoplastic progression of Barrett's esophagus. Oncogene.
25:3084–3092. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishii T, Murakami J, Notohara K, Cullings
HM, Sasamoto H, Kambara T, Shirakawa Y, Naomoto Y, Ouchida M,
Shimizu K, et al: Oesophageal squamous cell carcinoma may develop
within a background of accumulating DNA methylation in normal and
dysplastic mucosa. Gut. 56:13–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu C, Li N, Lu H, Wang Z, Chen C, Wu L,
Liu J, Lu Y and Wang F: Circulating SFRP1 promoter methylation
status in gastric adenocarcinoma and esophageal square cell
carcinoma. Biomed Rep. 3:123–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu JB, Qiang FL, Dong J, Cai J, Zhou SH,
Shi MX, Chen KP and Hu ZB: Plasma DNA methylation of Wnt
antagonists predicts recurrence of esophageal squamous cell
carcinoma. World J Gastroenterol. 17:4917–4921. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meng Y, Wang QG, Wang JX, Zhu ST, Jiao Y,
Li P and Zhang ST: Epigenetic inactivation of the SFRP1 gene in
esophageal squamous cell carcinoma. Dig Dis Sci. 56:3195–3203.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zou H, Molina JR, Harrington JJ, Osborn
NK, Klatt KK, Romero Y, Burgart LJ and Ahlquist DA: Aberrant
methylation of secreted frizzled-related protein genes in
esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer.
116:584–591. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng YY, Yu J, Wong YP, Man EP, To KF,
Jin VX, Li J, Tao Q, Sung JJ, Chan FK and Leung WK: Frequent
epigenetic inactivation of secreted frizzled-related protein 2
(SFRP2) by promoter methylation in human gastric cancer. Br J
Cancer. 97:895–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guo Y, Guo W, Chen Z, Kuang G, Yang Z and
Dong Z: Hypermethylation and aberrant expression of Wnt-antagonist
family genes in gastric cardia adenocarcinoma. Neoplasma.
58:110–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kinoshita T, Nomoto S, Kodera Y, Koike M,
Fujiwara M and Nakao A: Decreased expression and aberrant
hypermethylation of the SFRP genes in human gastric cancer.
Hepatogastroenterology. 58:1051–1056. 2011.PubMed/NCBI
|
|
46
|
Liu JB, Wu XM, Cai J, Zhang JY, Zhang JL,
Zhou SH, Shi MX and Qiang FL: CpG island methylator phenotype and
Helicobacter pylori infection associated with gastric cancer. World
J Gastroenterol. 18:5129–5134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao CH, Bu XM and Zhang N:
Hypermethylation and aberrant expression of Wnt antagonist secreted
frizzled-related protein 1 in gastric cancer. World J
Gastroenterol. 13:2214–2217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rettori MM, de Carvalho AC, Longo AL, de
Oliveira CZ, Kowalski LP, Carvalho AL and Vettore AL: TIMP3 and
CCNA1 hypermethylation in HNSCC is associated with an increased
incidence of second primary tumors. J Transl Med. 11:3162013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ding SL, Yang ZW, Wang J, Zhang XL, Chen
XM and Lu FM: Integrative analysis of aberrant Wnt signaling in
hepatitis B virus-related hepatocellular carcinoma. World J
Gastroenterol. 21:6317–6328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Feng Q, Stern JE, Hawes SE, Lu H, Jiang M
and Kiviat NB: DNA methylation changes in normal liver tissues and
hepatocellular carcinoma with different viral infection. Exp Mol
Pathol. 88:287–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hua D, Hu Y, Wu YY, Cheng ZH, Yu J, Du X
and Huang ZH: Quantitative methylation analysis of multiple genes
using methylation-sensitive restriction enzyme-based quantitative
PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol.
91:455–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu JB, Zhang YX, Zhou SH, Shi MX, Cai J,
Liu Y, Chen KP and Qiang FL: CpG island methylator phenotype in
plasma is associated with hepatocellular carcinoma prognosis. World
J Gastroenterol. 17:4718–4724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nomoto S, Kinoshita T, Kato K, Otani S,
Kasuya H, Takeda S, Kanazumi N, Sugimoto H and Nakao A:
Hypermethylation of multiple genes as clonal markers in
multicentric hepatocellular carcinoma. Br J Cancer. 97:1260–1265.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu
KY, Chu TY and Lin YW: Promoter methylation of the secreted
frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular
carcinoma. Cancer. 107:579–590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Uhm KO, Lee ES, Lee YM, Park JS, Kim SJ,
Kim BS, Kim HS and Park SH: Differential methylation pattern of
ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic
myeloid leukemia. J Korean Med Sci. 24:493–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pehlivan M, Sercan Z and Sercan HO: sFRP1
promoter methylation is associated with persistent Philadelphia
chromosome in chronic myeloid leukemia. Leuk Res. 33:1062–1067.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shen JZ, Xu CB, Fu HY, Wu DS, Zhou HR and
Fan LP: Methylation of secreted frizzled related protein gene in
acute leukemia patients in China. Asian Pac J Cancer Prev.
12:2617–2621. 2011.PubMed/NCBI
|
|
58
|
Suzuki M, Shigematsu H, Nakajima T, Kubo
R, Motohashi S, Sekine Y, Shibuya K, Iizasa T, Hiroshima K,
Nakatani Y, et al: Synchronous alterations of Wnt and epidermal
growth factor receptor signaling pathways through aberrant
methylation and mutation in non small cell lung cancer. Clin Cancer
Res. 13:6087–6092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yoshino M, Suzuki M, Tian L, Moriya Y,
Hoshino H, Okamoto T, Yoshida S, Shibuya K and Yoshino I: Promoter
hypermethylation of the p16 and Wif-1 genes as an independent
prognostic marker in stage IA non-small cell lung cancers. Int J
Oncol. 35:1201–1209. 2009.PubMed/NCBI
|
|
60
|
Zhang YW, Miao YF, Yi J, Geng J, Wang R
and Chen LB: Transcriptional inactivation of secreted
frizzled-related protein 1 by promoter hypermethylation as a
potential biomarker for non-small cell lung cancer. Neoplasma.
57:228–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang Y, Wang R, Song H, Huang G, Yi J,
Zheng Y, Wan J and Chen L: Methylation of multiple genes as a
candidate biomarker in non-small cell lung cancer. Cancer Lett.
303:21–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lee CH, Hung YJ, Lin CY, Hung PH, Hung HW
and Shieh YS: Loss of SFRP1 expression is associated with aberrant
beta-catenin distribution and tumor progression in mucoepidermoid
carcinoma of salivary glands. Ann Surg Oncol. 17:2237–2246. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chim CS, Pang R, Fung TK, Choi CL and
Liang R: Epigenetic dysregulation of Wnt signaling pathway in
multiple myeloma. Leukemia. 21:2527–2536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chang Q, Pang JC, Li KK, Poon WS, Zhou L
and Ng HK: Promoter hypermethylation profile of RASSF1A, FHIT, and
sFRP1 in intracranial primitive neuroectodermal tumors. Hum Pathol.
36:1265–1272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Al-Shabanah OA, Hafez MM, Hassan ZK,
Sayed-Ahmed MM, Abozeed WN, Alsheikh A and Al-Rejaie SS:
Methylation of SFRPs and APC genes in ovarian cancer infected with
high risk human papillomavirus. Asian Pac J Cancer Prev.
15:2719–2725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Su HY, Lai HC, Lin YW, Chou YC, Liu CY and
Yu MH: An epigenetic marker panel for screening and prognostic
prediction of ovarian cancer. Int J Cancer. 124:387–393. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bu XM, Zhao CH, Zhang N, Gao F, Lin S and
Dai XW: Hypermethylation and aberrant expression of secreted
frizzled-related protein genes in pancreatic cancer. World J
Gastroenterol. 14:3421–3424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Awakura Y, Nakamura E, Ito N, Kamoto T and
Ogawa O: Methylation-associated silencing of SFRP1 in renal cell
carcinoma. Oncol Rep. 20:1257–1263. 2008.PubMed/NCBI
|
|
69
|
Gumz ML, Zou H, Kreinest PA, Childs AC,
Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, et
al: Secreted frizzled-related protein 1 loss contributes to tumor
phenotype of clear cell renal cell carcinoma. Clin Cancer Res.
13:4740–4749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Morris MR, Ricketts C, Gentle D,
Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F and
Maher ER: Identification of candidate tumour suppressor genes
frequently methylated in renal cell carcinoma. Oncogene.
29:2104–2117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Urakami S, Shiina H, Enokida H, Hirata H,
Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, et
al: Wnt antagonist family genes as biomarkers for diagnosis,
staging, and prognosis of renal cell carcinoma using tumor and
serum DNA. Clin Cancer Res. 12:6989–6997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Babaei H, Mohammadi M and Salehi R: DNA
methylation analysis of secreted frizzled-related protein 2 gene
for the early detection of colorectal cancer in fecal DNA. Niger
Med J. 57:242–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bagci B, Sari M, Karadayi K, Turan M,
Ozdemir O and Bagci G: KRAS, BRAF oncogene mutations and tissue
specific promoter hypermethylation of tumor suppressor SFRP2,
DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Cancer Biomark. 17:133–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chang E, Park DI, Kim YJ, Kim BK, Park JH,
Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, et al: Detection of
colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and
p16 in stool samples: A preliminary report in Korean patients.
Hepatogastroenterology. 57:720–727. 2010.PubMed/NCBI
|
|
75
|
Huang ZH, Li LH, Yang F and Wang JF:
Detection of aberrant methylation in fecal DNA as a molecular
screening tool for colorectal cancer and precancerous lesions.
World J Gastroenterol. 13:950–954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Leung WK, To KF, Man EP, Chan MW, Hui AJ,
Ng SS, Lau JY and Sung JJ: Detection of hypermethylated DNA or
cyclooxygenase-2 messenger RNA in fecal samples of patients with
colorectal cancer or polyps. Am J Gastroenterol. 102:1070–1076.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lu H, Huang S, Zhang X, Wang D, Zhang X,
Yuan X, Zhang Q and Huang Z: DNA methylation analysis of SFRP2,
GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in
fecal DNA. Oncol Lett. 8:1751–1756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Müller HM, Oberwalder M, Fiegl H,
Morandell M, Goebel G, Zitt M, Mühlthaler M, Ofner D, Margreiter R
and Widschwendter M: Methylation changes in faecal DNA: A marker
for colorectal cancer screening? Lancet. 363:1283–1285. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Park SK, Song CS, Yang HJ, Jung YS, Choi
KY, Koo DH, Kim KE, Jeong KU, Kim HO, Kim H, et al: Erratum: Field
cancerization in sporadic colon cancer. Gut Liver. 10:9812016.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pehlivan S, Artac M, Sever T, Bozcuk H,
Kilincarslan C and Pehlivan M: Gene methylation of SFRP2, P16,
DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal
cancer. Cancer Genet Cytogenet. 201:128–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Tang D, Liu J, Wang DR, Yu HF, Li YK and
Zhang JQ: Diagnostic and prognostic value of the methylation status
of secreted frizzled-related protein 2 in colorectal cancer. Clin
Invest Med. 34:E88–E95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang DR and Tang D: Hypermethylated SFRP2
gene in fecal DNA is a high potential biomarker for colorectal
cancer noninvasive screening. World J Gastroenterol. 14:524–531.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Yang W, Wang X, Li X, Wang M, Chen X, Wu
X, Wang Y, Fan Y and Jin H: The specific methylation
characteristics of cancer related genes in Chinese colorectal
cancer patients. Tumour Biol. 35:8267–8279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang X, Song YF, Lu HN, Wang DP, Zhang
XS, Huang SL, Sun BL and Huang ZG: Combined detection of plasma
GATA5 and SFRP2 methylation is a valid noninvasive biomarker for
colorectal cancer and adenomas. World J Gastroenterol.
21:2629–2637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Samaei NM, Yazdani Y, Alizadeh-Navaei R,
Azadeh H and Farazmandfar T: Promoter methylation analysis of
WNT/β-catenin pathway regulators and its association with
expression of DNMT1 enzyme in colorectal cancer. J Biomed Sci.
21:732014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Suehiro Y, Okada T, Okada T, Anno K,
Okayama N, Ueno K, Hiura M, Nakamura M, Kondo T, Oga A, et al:
Aneuploidy predicts outcome in patients with endometrial carcinoma
and is related to lack of CDH13 hypermethylation. Clin Cancer Res.
14:3354–3361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hao XW, Zhu ST, He YL, Li P, Wang YJ and
Zhang ST: Epigenetic inactivation of secreted frizzled-related
protein 2 in esophageal squamous cell carcinoma. World J
Gastroenterol. 18:532–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Nishida N, Nagasaka T, Nishimura T, Ikai
I, Boland CR and Goel A: Aberrant methylation of multiple tumor
suppressor genes in aging liver, chronic hepatitis, and
hepatocellular carcinoma. Hepatology. 47:908–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xiao C, Wang L, Zhu L, Zhang C and Zhou J:
Secreted frizzled- related protein 2 is epigenetically silenced and
functions as a tumor suppressor in oral squamous cell carcinoma.
Mol Med Rep. 10:2293–2298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Perry AS, O'Hurley G, Raheem OA, Brennan
K, Wong S, O'Grady A, Kennedy AM, Marignol L, Murphy TM, Sullivan
L, et al: Gene expression and epigenetic discovery screen reveal
methylation of SFRP2 in prostate cancer. Int J Cancer.
132:1771–1780. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Brebi P, Hoffstetter R, Andana A, Ili CG,
Saavedra K, Viscarra T, Retamal J, Sanchez R and Roa JC: Evaluation
of ZAR1 and SFRP4 methylation status as potentials biomarkers for
diagnosis in cervical cancer: Exploratory study phase I.
Biomarkers. 19:181–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhao C, Bu X, Zhang N and Wang W:
Downregulation of SFRP5 expression and its inverse correlation with
those of MMP-7 and MT1-MMP in gastric cancer. BMC Cancer.
9:2242009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Takeda M, Nagasaka T, Dong-Sheng S, Nishie
H, Oka T, Yamada E, Mori Y, Shigeyasu K, Morikawa T, Mizobuchi S
and Fujiwara T: Expansion of CpG methylation in the SFRP2 promoter
region during colorectal tumorigenesis. Acta Med Okayama.
65:169–177. 2011.PubMed/NCBI
|
|
94
|
Sidransky D, Tokino T, Hamilton SR,
Kinzler KW, Levin B, Frost P and Vogelstein B: Identification of
ras oncogene mutations in the stool of patients with curable
colorectal tumors. Science. 256:102–105. 1992. View Article : Google Scholar : PubMed/NCBI
|
